Trial intelligence / Profile preview

Methotrexate + Glucocorticoids for Acute GVHD

NCT00357084Phase 2Completed

Sponsor
Fred Hutchinson Cancer Center
Start
May 2006
Primary completion
Aug 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methotrexate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Fred Hutchinson Cancer Center. Started May 2006; status: completed.

02

Drugs

methotrexate
03

Conditions

Acute Graft-Versus-Host Disease (aGvHD)

Beyond the preview

Go deeper on NCT00357084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00357084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call